Chemoinformaics analysis of Tricyclene
Molecular Weight | 136.238 | nRot | 0 |
Heavy Atom Molecular Weight | 120.11 | nRig | 9 |
Exact Molecular Weight | 136.125 | nRing | 4 |
Solubility: LogS | -4.94 | nHRing | 0 |
Solubility: LogP | 3.828 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 4 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 27.3687 |
nHD | 0 | BPOL | 16.0513 |
QED | 0.48 |
Synth | 4.929 |
Natural Product Likeliness | 2.314 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.006 |
CACO-2 | -4.525 |
MDCK | 0.0000173 |
BBB | 0.918 |
PPB | 0.858095 |
VDSS | 1.516 |
FU | 0.173348 |
CYP1A2-inh | 0.375 |
CYP1A2-sub | 0.768 |
CYP2c19-inh | 0.47 |
CYP2c19-sub | 0.939 |
CYP2c9-inh | 0.398 |
CYP2c9-sub | 0.958 |
CYP2d6-inh | 0.026 |
CYP2d6-sub | 0.829 |
CYP3a4-inh | 0.077 |
CYP3a4-sub | 0.233 |
CL | 13.134 |
T12 | 0.117 |
hERG | 0.019 |
Ames | 0.011 |
ROA | 0.075 |
SkinSen | 0.294 |
Carcinogencity | 0.07 |
EI | 0.984 |
Respiratory | 0.937 |
NR-Aromatase | 0.011 |
Antiviral | No |
Prediction | 0.895889 |